Kimia Therapeutics
About:
Kimia is a drug discovery company applying high throughput precision chemistry in combination.
Website: https://www.kimiatx.com
Top Investors: The Column Group, Horizons Ventures, Dimension
Description:
KimiaTherapeutics is a drug discovery business that uses high throughput precision chemistry in conjunction with genome editing and machine learning to uncover druggable sites at crucial nodes of intervention in human disease.
Total Funding Amount:
$55M
Headquarters Location:
Berkeley, California, United States
Founded Date:
2022-01-01
Founders:
Jack Sadowsky, Ray Fucini, Stig Hansen
Number of Employees:
11-50
Last Funding Date:
2023-12-19
IPO Status:
Private
Industries:
© 2025 bioDAO.ai